Brief: Consun Pharmaceutical updates on equity transfer agreement with Fifth Round Vendor
June 20 (Reuters) - Consun Pharmaceutical Group Ltd 1681.HK : * Says unit has entered into the equity transfer agreement with the fifth round vendor on 17 June 2016 * Consideration for fifth round acquisition approximately RMB31.6 million * Says to further acquire approximately 3.60% equity interest in the target company, guangxi yulin pharmaceutical group co * Source text (http://bit.ly/28ISuXH) ((For more news, please click here 1681.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director